'Minor bleeding' presentation slideshows

METHODOLOGY:

Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura : prospective cohort study.

370 views • 20 slides

CARDIOPATIA ISCHEMICA

564 views • 17 slides

American Journal of Cardiology 2008; 102: 1618-1623

Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy

267 views • 14 slides

TIMI 30: The PROTECT Trial

TIMI 30: The PROTECT Trial. High-risk UA/NSTEMI for PCI of a native coronary artery with either DM; or + Troponin; or ST ? ? 0.5 mm; or TRS > 3. N = 857. TRANSFER TO CATH LAB, DIAGNOSTIC ANGIOGRAM. CONFIRM ELIGIBLE FOR PCI OF CULPRIT IN NATIVE ARTERY . Eptifibatide

291 views • 9 slides

Clinical presentation & outcomes of stent thrombosis Spanish registry ESTROFA (n=23,500)

Clinical presentation & outcomes of stent thrombosis Spanish registry ESTROFA (n=23,500). Overall (n=301). Acute/Subacute (n=149). Late (n=152). p. Presentation. STEMI. 83.7%. 86%. 81.5%. 0.36. Shock. 20.5%. 21%. 20.4%. 0.98. TIMI 0/1. 88%. 92%. 84.2%. 0.056. Outcomes.

157 views • 5 slides

Clinical presentation & outcomes of stent thrombosis Spanish registry ESTROFA (n=23,500)

Clinical presentation & outcomes of stent thrombosis Spanish registry ESTROFA (n=23,500). Overall (n=301). Acute/Subacute (n=149). Late (n=152). p. Presentation. STEMI. 83.7%. 86%. 81.5%. 0.36. Shock. 20.5%. 21%. 20.4%. 0.98. TIMI 0/1. 88%. 92%. 84.2%. 0.056. Outcomes.

67 views • 5 slides